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Abstract
Background:  Patellofemoral complaints are frequently seen in younger and active patients.
Clinical strategy is usually based on decreasing provoking activities as sports and demanding knee
activities during work and leisure and reassuring the patient on the presumed good outcome.
Exercise therapy is also often prescribed although evidence on effectiveness is lacking.
The objective of this article is to present the design of a randomized clinical trial that examines the
outcome of exercise therapy supervised by a physical therapist versus a clinically accepted "wait
and see" approach (information and advice about the complaints only).
The research will address to both effectiveness and cost effectiveness of supervised exercise
therapy in patients with patellofemoral pain syndrome (PFPS).
Methods/design: 136 patients (adolescents and young adults) with patellofemoral pain syndrome
are recruited in general practices and sport medicine centers. They will be randomly allocated
receiving either 3 months of exercise therapy (or usual care.
The primary outcome measures are pain, knee function and perception of recovery after 3 months
and 12 months of follow up and will be measured by self reporting.
Measurements will take place at baseline, 6 weeks, and 3 monthly until 1 year after inclusion in the
study.
Secondary outcome measurements include an economic evaluation.
A cost-utility analysis will be performed that expresses health improvements in Quality Adjusted
Life Years (QALYs) and incorporates direct medical costs and productivity costs
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Discussion: This study has been designed after reviewing the literature on exercise therapy for
patellofemoral pain syndrome. It was concluded that to merit the effect of exercise therapy a trial
based on correct methodological concept needed to be executed.
The PEX study is a randomized clinical trial where exercise therapy is compared to usual care. This 
trial started in April 2005 and will finish in June 2007. The first results will be available around 
December 2007.
Background
Patellofemoral pain syndrome (PFPS) is a common com-
plaint in adolescents and younger adults. Though exact
epidemiological data do not exist, 5–6 six new cases per
year in Dutch GP-practices may be expected [1]. The
symptom most frequently reported is a diffuse peripatel-
lar and retropatellar localized pain, typically provoked by
ascending or descending stairs, squatting, cycling and sit-
ting with flexed knees for prolonged periods of time [2,3].
Weakness of the knee extensors and abnormal firing pat-
terns of the nerves innervating these knee extensors have
been found in patients with PFPS. These phenomena are
thought to cause maltracking of the patella through the
femoral groove, resulting in increased intrapatellar pres-
sure. Tight anatomical structures and heavy physical load-
ing may add to the pressure. This pressure probably causes
patellofemoral pain.
PFPS frequently becomes a chronic problem, forcing the
patient to stop sports and other similar activities [4]. The
long-term prognosis is generally more favorable for young
patients, but seems to be independent of the presence of
cartilage damage or gender [5].
Clinical guidelines of the Dutch College of General Prac-
titioners [6] advise GPs to inform the patient about the
background of the condition and its favorable prognosis.
Patients are advised to refrain from all (sports-) activities
that provoke pain, and to find alternative exercises to keep
in shape. Non-weight bearing quadriceps strengthening
exercises may be considered, but the guidelines explicitly
mention that evidence for its effectiveness is lacking.
Patellar taping is not advised. In case of prolonged unre-
sponsive, severe complaints, referral to an orthopedic sur-
geon may be considered. General practitioners do not
always adhere to these guidelines and prescriptions for
analgesics such as paracetamol and NSAIDs to reduce
pain and referrals to physical therapists (exercise therapy)
are among the treatments regularly encountered (unpub-
lished data authors). People involved in sports and ath-
letic activities may consult sports clinics with their
symptoms. In sports clinics it is more common to refer to
physical therapy for exercises (unpublished data authors).
Evidence for the effectiveness of conservative therapies for
PFPS is scarcely available [2]. Exercise therapy is based on
the theoretical assumption that muscle weakness or
imbalance is a major contributor in the development of
PFPS. The recent Cochrane review [7] performed by our
group identified only 3 trials comparing exercise therapy
with a control group not receiving exercise therapy
We found limited evidence that exercise was beneficial,
though the quality of the trials was such that further
research was recommended to confirm this conclusion
[7]. Recently a small placebo controlled trial was pub-
lished investigating the short-term effectiveness of exer-
cise therapy combined with taping and passive manual
mobilization of the patella. The control group received
sham ultrasound and placebo-taping. The authors
reported beneficial effects in the intervention group (n =
33) compared the control group (n = 34) after 6 weeks fol-
low-up [8]. Cost effectiveness data are not available at all.
Because physicians, especially the GP and sports physi-
cian, frequently are confronted with patients with PFPS,
but by lack of evidence are unable to apply the most
(cost)effective treatment, a randomized intervention
study is highly indicated. The 'wait and see' policy advo-
cated in the guidelines should be compared to the more
active approach of exercise therapy under supervision of a
physical therapist, in order to assess (cost)effectiveness of
both approaches.
The trial will target patients (adolescents and young
adults) presenting in general practice and sports clinics
with the symptoms of PFPS and no history of previous
active treatment with exercises.
In this article we will present the detailed protocol of the
trial.
This trial started April 2005 and patients will be included
until June 2006.
Methods/design
Study design
This study is a randomized clinical trial to study short-
term and long-term (cost) effectiveness of exercise therapy
in combination with advice and information on the back-
ground of PFPS compared to advice and information on
the background of PFPS only ("wait and see")BMC Musculoskeletal Disorders 2006, 7:31 http://www.biomedcentral.com/1471-2474/7/31
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The study design (Figure 1) was approved by the Medical
Ethics Committee at the Erasmus MC – university medical
centre Rotterdam. All patients gave written informed con-
sent.
Patient selection
Patients eligible for this trial are adolescents and young
adults in the age of 14 to 40 years consulting the GP or
sports physician for PFPS lasting longer than two months
but not longer than 2 years. Recruitment will take place in
"HONEUR" practices (a research network of 38 general
practices allied with the Department of General Practice of
Erasmus MC) and in 4 sports medical centers in Rotter-
dam, Leidschendam, Breda and Gorinchem.
The recruitment period is planned from April 2005 until
June 2006.
In- and exclusion criteria
Inclusion criteria are the following diagnostic criteria;
Presence of at least 3 symptoms of the following: pain
when walking stairs, pain when squatting, pain when run-
ning, pain when cycling, pain when sitting with knees
flexed for a prolonged period of time, grinding of the
patella, positive physical tests (Clarke's test, Rabot sign,
patella release test).
The exclusion criteria are: knee osteoarthrosis/arthritis,
previous knee injury or knee operations, patellar tendin-
opathy, M. Osgood Schlatter, or other defined pathologi-
cal conditions of the knee.
Sample size
Sample size is based on studies included in our systematic
review [7]. In a single study investigating a similar contrast
of interventions [9] there was an absolute increase in
recovery of 22% (19% recovery in the usual care group to
41% recovery in the exercise therapy group) after one year,
OR 2.21 (95%CI 0.87 – 5.64)). This represents a clinically
relevant increase and is expected to be even more pro-
nounced after 3 months follow-up. Such a difference can
be detected statistically (power 0.80, alpha 0.05 one-sided
test) with 61 patients per group. With a potential dropout
rate of 10% a total of 136 patients should be included.
Intervention
The interventions that will be compared in this trial are:
A) Exercise therapy for a period of 6 weeks, provided by a
physical therapist according to a standardized protocol
drawn up according to present international expert opin-
ion and modified by local participating physical thera-
pists into a practical protocol which is feasible in daily
practice. The program consists of static and dynamic mus-
cular exercises for quadriceps muscles, balance exercises
and flexibility exercises. Patients are directed to practice 7
times a week during 20 minutes.
Instructions concerning the exercises will be noted on the
"workout book" (Figure 2) which has been designed for
the study. The notes regarding frequency and duration of
exercises is send to the investigators after the three month
period of exercise.
Patients will receive standardized information about the
background and prognosis of PFPS on a specially
designed leaflet. After the period of 6 weeks patients will
be advised to keep up the exercises at home for the follow-
ing 6 weeks.
B) The control group will receive the standardized infor-
mation and advice. This advice consists of the informa-
tion usually given by GPs, according to the guidelines:
information about the background of the condition and
its good prognosis, advice to refrain from all (sports-)
Flowchart of the study design Figure 1
Flowchart of the study design.
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activities that provoke pain, and to find alternatives to
keep in shape.
An information leaflet for the patients has been compiled
to contribute to the standardization for both groups.
Co-interventions
During the one year follow-up other interventions like the
use of ice applications, bandages or braces, or consump-
tion of oral analgesics (NSAIDs or paracetamol) indicated
by pain severity are allowed for both groups. Information
about these co-interventions will be collected after 6
weeks and every 3 months and during one year follow-up
and will be used in the cost-effectiveness analysis.
Randomization
After recruitment through the participating GP's and sport
physicians the patient is finally accepted in the study after
written informed consent and reassessment of the inclu-
sion and exclusion criteria.
Following this informed consent and baseline assess-
ments, patients are allocated to the intervention or control
group using a blinded and computer based randomiza-
tion list.
The randomization table will be stratified for the setting
(general practice versus sports clinic) and for age (14–18
versus 19–40). Patient are informed about the treatment
allocation and subsequently the patients in the exercise
group receive their treatment from a physical therapist in
a predetermined centre, whereas patients in the control
group will not receive this intervention.
Measurements
Outcome parameters
Primary outcome measures are: perceived recovery (meas-
ured with a 7 point Likert scale [10] functional disability
using a disease-specific disability scale (Kujala Patellofem-
oral Scale) [11] and a pain severity using a numerical rat-
ing scale[12] after 3 and 12 months of follow-up. (Table
1)
Secondary outcome measures are cost-effectiveness after
one year, the primary outcome parameters at 6 weeks fol-
low-up, quality of life (Euroqol)[13] and a numerical rat-
ing scale (NRS 0–10) for difficulties encountered during
work, school or sports activities. Medical consumption
(visits to health care providers and consumptions of pre-
scription or over the counter medication), absence from
work or decreased productivity at work, and other indirect
an direct costs are all included in the economic evalua-
tion.
Baseline and follow-up questionnaires at 6 weeks and 3
and 12 months will be filled out by the patients them-
selves. Quality of life, direct costs and productivity costs
and compliance to the interventions will be measured
after 6 weeks and every 3 months during one year also by
self report.
Analyses
All analyses will take place after the trial has finished, no
intermediate analyses will be performed.
To evaluate the effectiveness of supervised exercise ther-
apy in patients with PFPS differences in clinical outcome
measures between intervention and control group will be
analyzed on the basis of intention to treat. Additionally,
analysis per protocol will be conducted. Dichotomous
Sheet from the workout book with example exercises Figure 2
Sheet from the workout book with example exercises.
D 
Straight leg raising 
Straight leg raising 
(prone) 
(leg in external rotation) 
3 series, 30 reps 
  
E 
Leg extensions:  
10° ° ° ° flexion to full 
extension 
3 series, 30 reps 
  
F 
Isometric VMO/ 
Adductor Magnus 
contraction in full 
extension 
Contraction of 
quadriceps muscles, 
external rotation of the 
foot. 
3 series, 8 reps, 10-15 
seconds BMC Musculoskeletal Disorders 2006, 7:31 http://www.biomedcentral.com/1471-2474/7/31
Page 5 of 6
(page number not for citation purposes)
outcomes at three and 12 months follow-up will be ana-
lyzed using logistic regression techniques and continuous
outcomes with linear regression techniques. Of the pri-
mary outcomes perceived recovery will be dichotomized
to recovered (fully, strongly) or not recovered (slightly-
strongly worsened). Other primary outcome measure-
ments will be analyzed as continuous variables
Analyses will be adjusted for baseline values and for co-
interventions and possible prognostic factors in case the
effect estimate changes with more than 10% when includ-
ing these variables in the model.
Additionally the overall one year dichotomous outcomes
will be analyzed using GEE (generalized estimating equa-
tions) [14], continuous outcomes will be analyzed using
linear regression for repeated measurements. Both tech-
niques take the correlation of multiple measurements
within one patient into account.
Research question 2 "What is the cost-effectiveness of
supervised exercise therapy in patients with PFPS...." is the
basis for the economic evaluation.
In the economic evaluation (a cost utility analysis) both
the costs and the consequences of both treatment options
are compared and incremental costs and incremental
health effects the latter (in terms of quality of life) is esti-
mated.
The economic evaluation is performed alongside the ran-
domized clinical trial. Patients will complete question-
naires for costs and quality of life after 6 weeks and every
3 months. Only if the difference in health between the
treatment arms appears not to be stable over time, an
additional modeling study using a Markov model will be
performed. Statistical methods are used to describe uncer-
tainty in costs and effects estimates based on patient data.
A 95% confidence interval for the cost-utility ratio will be
calculated and an acceptability curve will be presented
Cost-analysis
For the economic evaluation a societal perspective is
employed. The relevant costs are divided into direct med-
ical costs and productivity costs.
- Direct costs
The costs of health care utilization during the twelve
months follow-up consist of visits to a general practi-
tioner, medical specialist, physiotherapist, manual thera-
pist, prescribed and over the counter (OTC) medicines,
alternative practitioners and hospitalization and appli-
ances. In the patient questionnaire we ask for the health
care consumption in the past six weeks. The costs for the
period between two measurements (mostly 3 months) are
established through linear interpolation. The medical
consumption is valued based on resource costs and guide-
line costs [15]
- Productivity costs
The productivity costs are defined as the costs of absence
from work due to PFPS, including the impact of compen-
sation mechanisms [16] the costs of efficiency loss due to
PFPS and the costs of hindrance at unpaid work. In the
questionnaire the patients are asked to report the reason
for absence from work and the number of absent days
[17]. To this end we will use the PRODISQ questionnaire
[18]. The valuation of an hour work the average produc-
tivity costs per hour worked will be based on the Net
National Income per working hour[15]. The friction cost
method is used to value the productivity costs related to
paid work [19]. Productivity costs can also occur when
people with health complaints are still working, but at a
lower productivity level. This is called efficiency loss. The
efficiency losses without absence are established by means
of the Quality and Quantity-method [13]. Productivity
losses at unpaid work are assessed by hindrance at unpaid
work and the number of hours that housekeeping tasks
were taken over by other people, and for how many hours
paid help was needed. The costs of one hour of house-
keeping tasks is set at the current price of one hour of sim-
ple professional home care.
- Patient outcome analysis in the economic evaluation
The patellar pain may affect Health Related Quality of
Life. This is measured with a generic instrument, the Euro-
Qol instrument EQ-5D [20,21] The EQ-5D descriptive
system consists of five dimensions (Mobility, Self Care,
Usual Activities, Pain/Discomfort and Anxiety/Depres-
sion) with three levels each (no problems, some problems
and extreme problems), thus defining 243 (35) distinct
health states. Respondents of the EuroQol EQ-5D
describe their own health using this descriptive system.
Preference weights based on the Time Trade-Off method
for the 243 EQ-5D health states are available from a large-
scale study in the UK[20,21]and a recent Dutch study [22]
Table 1: Questionnaires for primary and secondary outcome 
measurements
Primary outcome measurements
Perceived recovery - Likert scale
Functional disability - Kujala Patellofemoral Scale
Pain Severity - Numerical Rating Scale (NRS)
Secondary outcome measurements
Direct medical costs - Healthcare consumption
Productivity costs - PRODISQ
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to calculate EQ-5D index scores that can be used as utili-
ties to calculate QALYs.
Discussion
The PEX-study has been designed after reviewing the liter-
ature on exercise therapy for patellofemoral pain syn-
drome [7]. It was concluded that though exercise therapy
may have a beneficial effect on PFPS the scientific evi-
dence is limited due to small sample size and a small
amount of studies including a control group.
Based on available literature our research group expects to
discover (beneficial) changes from exercise therapy in per-
ceived recovery, pain severity and functional disability in
the PEX study.
The PEX study is a randomized clinical trial where exercise
therapy is compared to usual care. The trial started in April
2005 and is expected to finish in June 2007. The first
results will be available around December 2007.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
SMABZ, BWK and EMH conceived of the study, developed
the design of this trial and contributed to the content of
the article. MAK, JANV and MYB participated in the design
of the study. RL participated in the design and coordina-
tion of the study and wrote the article. MM coordinates
the trial and is responsible for data acquisition.
All authors read and approved the final article.
Acknowledgements
The PEX study was funded by a grant of ZON-MW (945-04-356).
References
1. Van der Velden J: Een nationale studie naar ziekten en verrich-
tingen in de huisartspraktijk. Basisrapport: morbiditeit in de
huisartspraktijk. .  Utrecht:, NIVEL; 1991. 
2. Arroll B, Ellis-Pegler E, Edwards A, Sutcliffe G: Patellofemoral pain
syndrome. A critical review of the clinical trials on nonopera-
tive therapy.  Am J Sports Med 1997, 25:207-212.
3. Cutbill JW, Ladly KO, Bray RC, Thorne P, Verhoef M: Anterior
knee pain: a review.  Clin J Sport Med 1997, 7:40-45.
4. Witvrouw E, Lysens R, Bellemans J, Cambier D, Vanderstraeten G:
Intrinsic risk factors for the development of anterior knee
pain in an athletic population. A two-year prospective study.
Am J Sports Med 2000, 28:480-489.
5. Natri A, Kannus P, Jarvinen M: Which factors predict the long-
term outcome in chronic patellofemoral pain syndrome? A
7-yr prospective follow-up study.  Med Sci Sports Exerc 1998,
30:1572-1577.
6. Cirkel JW, Klaassen WRC, Kunst JA, Aarns TEM, Plag EC, Gouds-
waard AN, Burgers JS: Niet-Traumatische knieproblemen bij
kinderen en adolescenten; NHG-Standaard.  Huisarts Wet
1998, 41:246-251.
7. Heintjes E, Berger MY, Bierma-Zeinstra SM, Bernsen RM, Verhaar JA,
Koes BW: Exercise therapy for patellofemoral pain syn-
drome.  Cochrane Database Syst Rev 2003:CD003472.
8. Crossley K, Bennell K, Green S, Cowan S, McConnell J: Physical
therapy for patellofemoral pain: a randomized, double-
blinded, placebo-controlled trial.  Am J Sports Med 2002,
30:857-865.
9. Clark DI, Downing N, Mitchell J, Coulson L, Syzpryt EP, Doherty M:
Physiotherapy for anterior knee pain: a randomised control-
led trial.  Ann Rheum Dis 2000, 59:700-704.
10. Van Der Heijden GJ, Leffers P, Wolters PJ, Verheijden JJ, van
Mameren H, Houben JP, Bouter LM, Knipschild PG: No effect of
bipolar interferential electrotherapy and pulsed ultrasound
for soft tissue shoulder disorders: a randomised controlled
trial.  Ann Rheum Dis 1999, 58:530-540.
11. Kujala UM, Jaakkola LH, Koskinen SK, Taimela S, Hurme M, Nelima-
rkka O: Scoring of patellofemoral disorders.  Arthroscopy 1993,
9:159-163.
12. Crossley KM, Bennell KL, Cowan SM, Green S: Analysis of out-
come measures for persons with patellofemoral pain: which
are reliable and valid?  Arch Phys Med Rehabil 2004, 85:815-822.
13. Brouwer WB, Koopmanschap MA, Rutten FF: Productivity losses
without absence: measurement validation and empirical evi-
dence.  Health Policy 1999, 48:13-27.
14. Diggle PJ, Liang KY, Zeger SL: Analysis of Longitudinal Data.
Oxford, Clarendon Press; 1994. 
15. Oostenbrink JB, Koopmanschap MA, Rutten FFH: Handleiding
voor kostenonderzoek; methoden en richtlijnprijzen voor
economische evaluaties in de gezondheidszorg.  Volume 1.
Amstelveen, College voor zorgverzekeringen; 2000. 
16. Jacob-Tacken KH, Koopmanschap MA, Meerding WJ, Severens JL:
Correcting for compensating mechanisms related to pro-
ductivity costs in economic evaluations of health care pro-
grammes.  Health Econ 2005, 14:435-443.
17. van Roijen L, Essink-Bot ML, Koopmanschap MA, Bonsel G, Rutten
FF: Labor and health status in economic evaluation of health
care. The Health and Labor Questionnaire.  Int J Technol Assess
Health Care 1996, 12:405-415.
18. Koopmanschap MA: PRODISQ: a modular questionnaire on
productivity and disease for economic evaluation studies.
Expert Rev Pharmacoeconomics Outcomes Res 2005, 5:23-28.
19. Koopmanschap MA, Rutten FF, van Ineveld BM, van Roijen L: The
friction cost method for measuring indirect costs of disease.
J Health Econ 1995, 14:171-189.
20. Brooks R: EuroQol: the current state of play.  Health Policy 1996,
37:53-72.
21. Dolan P, Gudex C, Kind P, Williams A: The time trade-off
method: results from a general population study.  Health Econ
1996, 5:141-154.
22. Lamers LM, Stalmeier PF, McDonnell J, Krabbe PF, van Busschbach JJ:
[Measuring the quality of life in economic evaluations: the
Dutch EQ-5D tariff].  Ned Tijdschr Geneeskd 2005, 149:1574-1578.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2474/7/31/prepub